Abbott To Market Ditropan XL For Five Years: Deal Parallels Alza Merger
Executive Summary
Abbott's co-promotion agreements for Ditropan XL with Alza ensure that Abbott will continue to detail the once-daily overactive bladder treatment for the next five years even if the companies do not complete their proposed merger.